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Background: Age of onset is an important outcome to characterize a population with a chronic disease. With
respect to social, cognitive, and physical aspects for patients and families, dementia is especially burdensome. In
Germany, like in many other countries, it is highly prevalent in the older population and imposes enormous efforts
for caregivers and society.
Methods: We develop an incidence-prevalence-mortality model to derive the mean and variance of the age of
onset in chronic diseases. Age- and sex-specific incidence and prevalence of dementia is taken from published
values based on health insurance data from 2002. Data about the age distribution in Germany in 2002 comes from
the Federal Statistical Office.
Results: Mean age of onset of a chronic disease depends on a) the age-specific incidence of the disease, b) the
prevalence of the disease, and c) the age distribution of the population. The resulting age of onset of dementia in
Germany in 2002 is 78.8 ± 8.1 years (mean ± standard deviation) for men and 81.9 ± 7.6 years for women.
Conclusions: Although incidence and prevalence of dementia in men are not greater than in women, men
contract dementia approximately three years earlier than women. The reason lies in the different age distributions
of the male and the female population in Germany.Introduction
Worldwide, dementia is a major public health problem
today and in the future. The current number of cases is
estimated to be 35.6 million, about one-fifth of those liv-
ing in Western Europe [1]. In Germany, the country
with most inhabitants in Europe, the number of cases
will likely double by 2050 [1]. Patients with dementia en-
counter a variety of limitations including social, cogni-
tive, psychological, and physical aspects with substantial
loss of quality of life for the patients themselves and also
for caregivers and families [2]. The economic impact of
dementia is enormous. Associated annual costs are
estimated at 604 billion US dollars worldwide and will
increase even more quickly than the prevalence [1].
Age of onset of a disease has been described as an
alternative to incidence as a measure for occurrence and
effect in epidemiology [3]. Traditionally, comparisons be-
tween groups with a factor present or absent are expressed* Correspondence: ralph.brinks@ddz.uni-duesseldorf.de
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reproduction in any medium, provided the oras relative risks. In common diseases with a high back-
ground risk, rate ratios between groups (i.e., ratios of
person-time incidence rates) cannot be interpreted as risk
ratios. In these cases, a statement that someone being ex-
posed to a risk factor contracts the disease, on average, a
number of years earlier than someone who is not exposed,
is easily interpretable to nonepidemiologists [3]. In deci-
sions of policy-makers, such as the planning of the need
for special care units and nursing homes, the age of onset
can be seen as a key measure. With respect to dementia,
the age of onset is hardly accessible by empirical studies.
In Germany, registers of newly diagnosed cases do not
exist, and representative surveys of the age of onset are
difficult to conduct. Besides presenting a feasible, new way
of estimating the mean age of onset of a chronic disease,
this article shows that age of onset depends on the age
distribution of the population under consideration.
Assuming that the age-course of the incidence is
known, we use a simple incidence-prevalence-mortality
(IPM) model for calculating the mean age of onset of
the chronic disease. In a first step, the general IPM
model is introduced. Then, formulas for the age of onsettd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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data on dementia.
Methods
In consideration of basic epidemiological parameters
such as incidence of, prevalence of, and mortality from a
disease, it is helpful to look at state (or compartmental)
models. The model used here consists of the three states
Normal, Disease, and Death and the transitions between
the states. Normal means healthy with respect to the
disease under consideration. The numbers of people in
the Normal state are denoted as S (susceptible), while in
the Disease state they are denoted as C (cases). The
transition rates are the incidence rate i and the mortality
rates m0 and m1 of the nondiseased and diseased people,
respectively (Figure 1).
Age of onset in the IPM model
In the general IPM model, the rates depend on calendar
time (t), age (a), and in the case of m1, the disease dur-
ation (d). For a specific point in time t* and a small time
period Δ > 0, the number of newly diseased people aged
a is about i(t*, a) S(t*, a) Δ. By integration we obtain the
number of all newly diseased people at time t* across all
ages:
∫w0 i t
; að Þ S t; að Þda: ð1Þ
The upper limit w in Equation (1) is the age of the
oldest member in the population. The mean age of onset
A tð Þ at time t* is obtained by weighting the integrand
in Equation (1) with the age a and dividing by the num-
ber of all newly diseased people. Hence it holds
A tð Þ ¼ ∫
w
0 a i t
; að Þ S t; að Þ da
∫w0 i t
; að Þ S t; að Þ da : ð2Þ
In practical applications the number S of nondiseased
subjects in a population is not accessible. By setting
N(t*, a) = S(t*, a) +C(t*, a) and p(t*, a) =C(t*, a)/N(t*, a),











Figure 1 IPM model. Simple model of a chronic disease with three
states. People in the state Normal are healthy with respect to the
considered disease. In the state Disease they suffer from the disease.
The transition rates depend on the calendar time t, on the age a,
and in the case of mortality m1 of the diseased people, on the
disease’s duration d.N(t*, a) is the (absolute) age distribution of the population,
and p(t*, a) is the age-specific prevalence at time t*. Then,
Equation (2) reads as
A tð Þ ¼ ∫
w
0 a i t
; að Þ 1−p t; að Þf gN t; að Þda
∫w0 i t
; að Þ 1−p t; að Þf gN t; að Þda : ð3Þ
Mostly, the age distribution N can be obtained from
official vital statistics of the population under consider-
ation. The incidence i and the prevalence p in Equation
(3) is subject to epidemiological studies.
By interpreting the mean age at onset as the first mo-
ment of a random variable A(t*), the corresponding vari-
ance is
Var A tð Þð Þ ¼ ∫
w
0 a−A t
ð Þð Þ2 i t; að Þ 1−p t; að Þf gN t; að Þda
∫w0 i t
; að Þ 1−p t; að Þf gN t; að Þda :
ð4Þ
Equations (3) and (4) hold true for subpopulations as
well. In many diseases, the incidence i, the prevalence p,
and the age distribution N differ substantially between
sexes. Thus, it may be useful to apply Equations (3) and
(4) to males and females separately.
Relations between incidence, prevalence, and mortality
Besides the age distribution N, Equations (3) and (4) de-
pend on the incidence i and the prevalence p. In cases
where one of i or p is unknown, it may be possible to ap-
proximate it. For this, we assume that the transition rates
do not depend on t or on d. In this situation Murray and
Lopez considered a system of ordinary differential equa-
tions (ODEs), which expresses the change in the numbers
of healthy and sick patients aged a with the corresponding
rates [4,5]. The system can be transformed into a scalar
ODE of Riccati type [6]:
dp=da ¼ 1−pð Þ  i−p : m1−m0ð Þf g:
ð5Þ
This equation relates the change in the prevalence at
age a to the rates i, m0, and m1. The advantage of such
closed-form ODEs includes the possibility of calculating
the age profile of the prevalence from given age-specific
incidence and mortality rates. Under certain smoothness
constraints, the incidence and mortality rates uniquely
determine the prevalence. In addition, for given preva-
lence and mortality rates the incidence can be obtained,
which allows cross-sectional studies to be used for inci-
dence estimates [6].
Application: dementia in Germany
The formulas developed above are applied to epidemio-
logical data on dementia in Germany. The age-specific
incidence has been taken from German health insurance
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been interpolated affine-linearly using the middle of the
age classes as knots. The mortality m of the general
population is taken from the life tables of the Federal
Statistical Office of Germany [8]. The reference year t* is
2002. The relative mortality R =m1/m0 is set constant to
R = 2.4 [9]. Although it is likely that R depends on a, the
age-specific values are not reported [9]. In case the gen-
eral mortality m = (1 – p) ·m0 + p ·m1 and the relative
mortality R are given, the ODE (2) changes its type and
becomes Abelian [10]:
dp=da ¼ 1−pð Þ  i–m : p : R–1ð Þ= p : R–1ð Þ þ 1½ f g:
ð6Þ
The age-specific prevalence for men and women is
derived by integrating the Abelian ODE (6) with initial
condition p(60) = 0 via the classical Runge-Kutta
method, cf. [11]. With N(2002, a) given for every age a = 0,
…, 99, 100+ from the official statistics [9], the integrals in
Equations (3) and (4) are replaced by sums. All calculations
are performed with the Software R (The R Foundation for
Statistical Computing), version 2.12.0.
Results
Figure 2 shows the age-specific prevalence of dementia
in Germany for males and females. In both cases, the
prevalence starts at 0 at the age of 60 years, which is the
initial condition. Until the age of 70 years, the preva-
lences of dementia in men and women are almost identi-
cal. Then the curves start to diverge, which is an effect
of the difference in general mortality. Incidence rates in
this age class are almost the same for men and women.
However, general mortality m for men is almost twice asFigure 2 Prevalence of dementia in Germany. Age- and sex-
specific prevalence of dementia after integration of the ODE (6).high as for women. It is striking that both prevalence
curves have a maximum at age a* = 96 years. At this age
it holds dp/da = 0.
The age distribution of the new cases of dementia
i(t*, a) · (1 – p(t*, a)) ·N(t*, a) for each age a = 60, …, 99,
100+ at t* = 2002 is shown in Figure 3 for males and fe-
males. Both distributions are left-skewed. The discontinu-
ities stem from the discontinuous structure of the age
distribution. Women are far more often affected than
men. The modus of the age of new cases is at age 80 and
85 in men and women, respectively.
The associated mean age of onset A tð Þ of dementia
together with the standard deviation are presented in
Table 1. On average, males contract the disease at the
age of 78.8 years, whereas females develop it three years
later at 81.9 years of age. The standard deviation of the
age of onset is similar in men and women at about
8 years. The source and data files for calculating these
numbers using the R software are provided as Additional
file 1 to this article.Discussion
The framework of the IPM model allows the calculation
of the mean age of onset of a chronic disease. One might
expect that the age at onset only depends on the disease,
that it is disease inherent. However, the age at onset
depends on the shape of the age distribution. The age
distribution is a subject of demography, and there are
population models where the numbers of people in the
age groups can be represented analytically. The simplest
example is the stationary population [12]. However, real
populations typically are nonstationary and have to beFigure 3 Age distribution of incident dementia. Age distribution
of the number of new cases (blue: males, red: females) in 2002
based on the age distribution N(2002, a) in Germany.
Table 1 Onset and duration of dementia for males and
females in Germany in 2002
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countries, the age structure of the population is captured
accurately by the Federal Statistical Office.
When applying the methods to dementia in Germany,
the mean age of onset of dementia is about 79 in men
and 82 in women. Due to the different life expectancies
of men and women in Germany, there are far more
females in the older age groups, and the difference is not
surprising. It is clear that there is a large difference in
the numbers of male and female patients with dementia.
Figure 4 shows the numbers of female and male patients
in each of the age groups. In 2002, a total of about
63,000 men and 147,000 women aged 60 years and
above fell ill. The reasons for this discrepancy between
men and women are twofold. First, the incidence of
dementia is higher in females, which leads to a higher
prevalence (see Figure 2). Second, the number of individ-
uals over 60 years is higher in females. For comparison,
there were only 8.5 million men and 11.6 million women
60 years and above in Germany in 2002 [8].
Another point is worth being mentioned: the exami-
nations in this paper predict a peak in the prevalence of
dementia in the second half of the ninth decade of life
for men and women. After the peak, prevalence de-
creases. In another survey from 2007 about theFigure 4 Age distribution of people with dementia. Age
distribution of the number of people with dementia (blue: males,
red: females) in 2002 based on the age distribution N(2002, a) in
Germany.prevalence of dementia in Germany, there are indica-
tions of the existence of a maximum in the age-specific
prevalence [13].
The analytical representations of the mean age of onset
and have several advantages. First, by the formulas (2) – (4)
the effects of interventions in chronic diseases on A tð Þ
can be estimated in advance. For example, if a prevention
program lowers the incidence of the disease by a certain
amount, the prevalence is lowered [6] and the impact of
the incidence reduction on A tð Þ can be predicted. Second,
by making the dependence of A tð Þ on the age distribution
explicit, the necessity of proper age profiles (or adjustment
methods) in epidemiological studies that survey age of
onset becomes obvious. With respect to surveying the age
of onset empirically (e.g., by questioning patients about
their age at date of diagnosis), Chen et al were aware of
the problem of choosing a representative age distribution
and gave some corresponding advice [14]. Finally, the
approach presented for the first time in this article allows
the estimation of the mean age of onset of dementia in the
entire relevant population of Germany. Currently, there
are no patient registers about dementia in Germany, and
surveys involving patients with dementia and relatives are
very difficult.
Nevertheless, this work has some weaknesses. First, our
way of calculating the age-specific prevalence of dementia
for men and women requires the incidence and mortality
rates to be independent from calendar time and independ-
ent from disease duration. These independence assump-
tions are hardly fulfilled in real data. In most populations,
mortality has a secular trend due to medical progress and
health awareness. Similarly, in the calculation of preva-
lence, the relative mortality is assumed to be constant for
all age groups and both sexes. This is unlikely to be true,
but more detailed data are lacking. However, the age- and
sex-specific prevalences are quite similar to another survey
[13], which gives justification for our method. Second, the
age distribution of the Federal Statistical Office does not
stratify ages beyond 100 years. The people 100 years and
above are summarized in one age class 100+. With a view
to the relatively low case numbers (see Figure 3), the effect
of this limitation is negligible. Third, the incidences are
based on claims data of the statutory health insurance
(SHI) from 2002. Therefore, age of onset actually means
age of diagnosis. Furthermore, there is a large proportion
of undetected cases in dementia [15,16], which are not
considered in the present study. Additionally, the rate of
officially diagnosed cases may depend on formal or reim-
bursement reasons or the sensibility for the disease.Conclusions
In the present work, an IPM model has been used to study
the age of onset of dementia. The mean age of onset
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and on the age distribution of the population under
consideration. If the age-specific prevalence is known,
the formulas for mean age of onset can be applied dir-
ectly. Alternatively, the age-specific prevalence inherent
in the numbers might be obtained as the solution of a
new ODE [6]. As a practical example, the calculations
were applied to data on dementia in Germany. The new
approach might be beneficial, because studying dementia
by empirical studies is very difficult. Characteristics of the
age of onset of dementia and the estimated numbers of
diseased people in different age groups are highly relevant
for health services allocation planning. The methods de-
scribed here help to predict characteristics of people with
chronic diseases (for instance the proportion of people
with walking disabilities or in need of care). The methods
also allow predictions on regional levels. Because age
distributions regionally differ quite substantially, the
associated mean ages of onset will be different as well.Additional file
Additional file 1: Data and source files for use with the statistical
software R.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
RB developed the methods, drafted the text, and made the programming.
SL proofread the programming. SL and RW critically revised the text,
methods, and results. All authors have given important intellectual
contributions and final approval of the version to be published.
Author details
1Institute for Biometry and Epidemiology, German Diabetes Center, Auf’m
Hennekamp 65, Duesseldorf 40225, Germany. 2Department of Public Health,
Heinrich Heine University, Duesseldorf 40225, Germany.
Received: 7 October 2012 Accepted: 30 April 2013
Published: 2 May 2013
References
1. World health organization and Alzheimer’s disease international: dementia: a
public health priority. http://www.who.int/mental_health/publications/
dementia_report_2012/en/.
2. Bruvik FK, Ulstein ID, Ranhoff AH, Engedal K: The quality of life of people
with dementia and their family carers. Dement Geriatr Cogn Disord 2012,
34(1):7–14.
3. Boshuizen HC: Average age at first occurrence as an alternative
occurrence parameter in epidemiology. Int J Epidemiol 1997,
26(4):867–872.
4. Murray CJL, Lopez AD: Quantifying disability: data, methods and results.
Bull WHO 1994, 72(3):481–494.
5. Murray CJL, Lopez AD: Global and regional descriptive epidemiology of
disability: incidence, prevalence, health expectancies and years lived
with disability. In The Global Burden of Disease. Edited by Murray CJL, Lopez
AD. Boston: Harvard School of Public Health; 1996:201–246.
6. Brinks R, Landwehr S, Icks A, Koch M, Giani G: Deriving age-specific
incidence from prevalence with an ordinary differential equation. Stat
Med 2012. http://dx.doi.org/10.1002/sim.5651.7. Ziegler U, Doblhammer G: Prävalenz und Inzidenz von Demenz in
Deutschland [Prevalence and incidence of dementia in Germany].
Gesundheitswesen 2009, 71(5):281–290.
8. Federal Statistical Office of Germany. http://www.destatis.de.
9. Rait G, Walters K, Bottomley C, Petersen I, Iliffe S, Nazareth I: Survival of
people with clinical diagnosis of dementia in primary care: cohort study.
BMJ 2010, 341:c3584.
10. Kamke E: Differentialgleichungen. Stuttgart: Teubner; 1983.
11. Dahlquist G, Björck A: Numerical Methods. Eaglewood Cliffs: Prentice-Hall;
1974.
12. Preston SH, Heuveline P, Guillot M: Demography. Malden: Blackwell; 2001.
13. Schulz A, Doblhammer G: Aktueller und zukünftiger Krankenbestand von
Demenz in Deutschland [Current and future number of patients with
dementia in Germany]. In Versorgungs-Report 2012. Edited by Guenster C,
Klose J, Schmacke N. Stuttgart: Schattauer; 2012:161–175.
14. Chen WJ, Faraone SV, Orav EJ, Tsuang MT: Estimating age at onset
distributions: the bias from prevalent cases and its impact on risk
estimation. Genet Epidemiol 1993, 10(1):43–59.
15. Bradford A, Kunik ME, Schulz P, Williams SP, Singh H: Missed and delayed
diagnosis of dementia in primary care: prevalence and contributing
factors. Alzheimer Dis Assoc Disord 2009, 23(4):306–314.
16. Connolly A, Gaehl E, Martin H, Morris J, Purandare N: Underdiagnosis of
dementia in primary care: variations in the observed prevalence and
comparisons to the expected prevalence. Aging Ment Health 2011, 15(8):
978–984.
doi:10.1186/1478-7954-11-6
Cite this article as: Brinks et al.: Age of onset in chronic diseases: new
method and application to dementia in Germany. Population Health
Metrics 2013 11:6.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
